Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Armata Pharmaceuticals (ARMP) has shared an update.
Mina Pastagia, M.D., has amended her employment terms with Armata Pharmaceuticals, reflecting her role as Chief Medical Officer since January 2023 and a base salary of $456,800. Starting in fiscal year 2024, she’s set for a 50% target annual bonus based on performance, with the potential for additional equity grants beginning in 2025. Should her employment end without cause or for good reason, she’s entitled to a year’s salary continuation, provided she adheres to certain conditions post-termination.
Learn more about ARMP stock on TipRanks’ Stock Analysis page.
